Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies-Reference-Cited by-同舟云学术

Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies

Published:2013-06-20 Issue:1 Volume:76 Page:78-88
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Baluom Muhammad¹,Grossbard Elliott B.¹,Mant Tim²,Lau David T. W.¹

Affiliation:

1. Rigel Pharmaceuticals, Inc.; South San Francisco; CA; USA

2. Quintiles Drug Research Unit at Guy's Hospital; London; UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12048/fullpdf

Reference24 articles.

1. Tyrosine kinase SYK: essential functions for immunoreceptor signaling;Turner;Immunol Today,2000

2. Src and Syk kinases: key regulators of phagocytic cell activation;Berton;Trends Immunol,2005

3. Fcγ receptors: old friends and new family members;Nimmerjahn;Immunity,2006

4. Spleen tyrosine kinase (SYK) biology, inhibitors and therapeutic applications;Singh;Annu Rep Med Chem,2007

5. Targeting Syk as a treatment for allergic and autoimmune disorders;Wong;Expert Opin Investig Drugs,2004

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the methoxy group in approved drugs;European Journal of Medicinal Chemistry;2024-07

2. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates;Chemical Society Reviews;2024

3. Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients;Current Opinion in Pharmacology;2023-02

4. IgA nephropathy: an overview of drug treatments in clinical trials;Expert Opinion on Investigational Drugs;2022-12-02

5. A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives;European Journal of Medicinal Chemistry;2022-12